$AZTR

Azitra, Inc.

CIK:0001701478|SEC Filings

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating expenses:
General and administrative	$ 2,067,639	$ 1,469,513	$ 4,440,998	$ 3,319,651
Research and development	1,351,529	1,401,839	2,912,094	2,651,939
Total operating expenses	3,419,168	2,871,352	7,353,092	5,971,590
Loss from operations	(3,419,168)	(2,871,352)	(7,353,092)	(5,971,590)
Other income (expense):
Interest income	74,661	15,461	89,380	52,625
Interest expense	(1,365)	(468)	(4,776)	(1,761)
Change in fair value of warrants	0	54	0	197
Other expense	(1,788)	(32,688)	(6,412)	(36,809)
Total other income (expense)	71,508	(17,641)	78,192	14,252
Loss before income taxes	(3,347,660)	(2,888,993)	(7,274,900)	(5,957,338)
Income tax expense	0	0	0	0
Net loss attributable to common shareholders	$ (3,347,660)	$ (2,888,993)	$ (7,274,900)	$ (5,957,338)
Net loss per share, basic (in dollars per share)	$ (0.17)	$ (1.18)	$ (0.42)	$ (2.69)
Net loss per share, diluted (in dollars per share)	$ (0.17)	$ (1.18)	$ (0.42)	$ (2.69)
Weighted average common stock outstanding, basic (in shares)	19,300,704	2,444,340	17,419,798	2,212,293
Weighted average common stock outstanding, diluted (in shares)	19,300,704	2,444,340	17,419,798	2,212,293

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (7,274,900)	$ (5,957,338)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	76,485	68,293
Gain/Loss on lease modification	(1,752)	7,726
Amortization of right-of-use assets	153,730	159,746
Stock based compensation	17,554	46,433
Change in fair value of warrant liability	0	(197)
Gain on disposal of property and equipment	0	(1,175)
Impairment of intangible assets and deferred patent costs	623,532	0
Changes in operating assets and liabilities:
Accounts receivable	3	233
Prepaid expenses	238,667	(107,984)
Other assets	360	(468)
Tax credits receivable	(3,438)	23,256
Income tax payable	(6,256)	(11,572)
Accounts payable and accrued expenses	557,223	40,432
Operating lease liability	(149,648)	(154,183)
Net cash used in operating activities	(5,768,440)	(5,886,798)
Cash flows from investing activities:
Purchases of property and equipment	(54,981)	(11,601)
Proceeds from sale of property and equipment	0	3,153
Deferred patent costs	(99,699)	(49,525)
Net cash used in investing activities	(154,680)	(57,973)
Cash flows from financing activities
Principal payments on finance leases	(8,625)	(7,838)
Proceeds from public offerings, net	0	1,749,312
Proceeds from exercise of warrants	196,800	0
Proceeds from private placement, net	10,377,703	0
Proceeds from equity line of credit	215,950	694,308
Repayment of insurance premium financing liability	(198,983)	0
Net cash provided by financing activities	10,582,845	2,435,782
Net change in cash and cash equivalents	4,659,725	(3,508,989)
Cash and cash equivalents at beginning of period	2,068,083	4,554,719
Cash and cash equivalents at end of period	6,727,808	1,045,730
Supplemental Cash Flow Information [Abstract]
Obtaining a right-of-use asset in exchange for lease liability	$ 166,690	$ 0

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 6,727,810	$ 2,068,083
Accounts receivable	909	912
Tax credits receivable	143,821	140,383
Prepaid expenses	571,282	809,949
Total current assets	7,443,822	3,019,327
Property and equipment, net	536,422	548,591
Financing lease right-of-use asset, net	1,301	9,041
Operating lease right-of-use asset, net	406,455	404,444
Intangible assets, net	330,039	316,673
Deferred patent costs	150,965	679,908
Other assets	47,042	47,402
Total assets	8,916,046	5,025,386
Current liabilities:
Accounts payable	497,985	399,356
Income tax payable	0	6,256
Current financing lease liability	1,486	10,111
Current operating lease liability	357,569	255,776
Insurance premium financing liability	0	198,983
Accrued expenses	673,669	197,484
Total current liabilities	1,530,709	1,067,966
Long-term operating lease liability	50,998	156,190
Total liabilities	1,581,707	1,224,156
Commitments and contingencies (Note 10)
Stockholders' equity
Preferred stock; $0.0001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025; respectively.	0	0
Common stock; $0.0001 par value, 750,000,000 and 200,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively, 60,603,742 and 10,740,697 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively.	6,060	1,074
Additional paid-in capital	83,124,375	72,321,352
Accumulated deficit	(75,796,096)	(68,521,196)
Total stockholders' equity	7,334,339	3,801,230
Total liabilities and stockholders' equity	$ 8,916,046	$ 5,025,386